Tadalafil tablets are the most widely represented dosage form of tadalafil, but 'tadalafil tablet' is not the name of one universal finished product. Oral tablets appear in Cialis and corresponding generic ED/BPH contexts as well as in the separate Adcirca PAH context, all of which use tadalafil as the active ingredient.
A finished tablet has several attributes beyond its milligram strength. Brand or manufacturer, indication, inactive ingredients, coating, shape, color, imprint, packaging and product-specific instructions can differ, so two tablets containing tadalafil do not have to look alike or belong to the same treatment framework.
This page focuses on those tablet-specific characteristics rather than functioning as a dose-selection guide. Detailed milligram architecture belongs on Tadalafil Strengths, while regimen questions belong on Tadalafil Dosage, Daily Tadalafil and As-Needed Tadalafil.
The tablet dosage form spans more than one tadalafil product and indication pathway. The most important distinction is therefore not simply whether a medicine is a tablet, but which finished product and labeling context that tablet belongs to.
The table below maps the main U.S. tablet contexts without attempting to reproduce each product's complete dosage instructions.
| Tablet Product Context | Product Example | Labeled Context | Deep Dive |
|---|---|---|---|
| Branded ED/BPH tadalafil tablet | Cialis | ED, BPH and combined ED/BPH | Cialis |
| Generic ED/BPH tadalafil tablet | Generic tadalafil referencing the Cialis-type context | ED, BPH and ED/BPH according to the applicable label | Generic Tadalafil |
| Branded PAH tadalafil tablet | Adcirca | PAH, WHO Group 1 | Adcirca |
| Generic PAH tadalafil tablet | Generic tadalafil referencing an appropriate PAH product | PAH according to the applicable product label | Tadalafil for Pulmonary Hypertension |
A tadalafil tablet is a solid oral dosage form containing tadalafil as its active pharmaceutical ingredient. The finished tablet also contains inactive ingredients needed for manufacturing, stability, disintegration, coating and other product characteristics.
The phrase identifies the active drug and dosage-form category, but it does not by itself identify the product's brand, manufacturer, strength, indication or regimen.
| Tablet Attribute | What It Describes |
|---|---|
| Active ingredient | Tadalafil |
| Dosage form | Solid oral tablet |
| Strength | Amount of tadalafil in one tablet |
| Brand / manufacturer | Identity of the finished product |
| Indication | Approved use associated with that product |
| Regimen | How the product is used within the relevant indication |
Current generic tadalafil labels in the Cialis-reference context commonly list 2.5 mg, 5 mg, 10 mg and 20 mg tablets. Those values do not form one universal progression from a 'weak' tablet to a 'strong' tablet; they appear in different daily and as-needed treatment frameworks.
The same strength can also appear in more than one product context. Twenty-milligram tadalafil, for example, exists in ED-related tablet products and in the separate Adcirca PAH tablet context, so milligram strength alone cannot identify intended use.
| Strength | Examples of Where It Appears | What Strength Alone Does Not Tell You |
|---|---|---|
| 2.5 mg | Generic Cialis-reference tablets; once-daily ED labeling | Whether it is the appropriate regimen for an individual |
| 5 mg | Branded and generic Cialis-type products across daily and some ED contexts | Which indication or schedule applies |
| 10 mg | Branded and generic Cialis-type tablet products | Whether dose adjustment is appropriate |
| 20 mg | ED-related tadalafil tablets and separate PAH tablet products such as Adcirca | Whether the tablet belongs to ED/BPH or PAH labeling |
Strength answers a product question: how much tadalafil is contained in one tablet. A dose and regimen answer different clinical questions and depend on the indication, product label, patient factors and other prescribing considerations.
For that reason, a strength list should not be read as a menu for choosing a tadalafil dose. Detailed numeric interpretation belongs on Tadalafil Strengths and regimen guidance on Tadalafil Dosage.
| Concept | Question It Answers |
|---|---|
| Tablet strength | How much tadalafil is in this tablet? |
| Dose | How much tadalafil is used at an administration? |
| Regimen | How is treatment scheduled? |
| Indication | What condition does the applicable label address? |
The current U.S. branded Cialis label lists 5 mg, 10 mg and 20 mg tablets in its Dosage Forms and Strengths section. The same current label still describes 2.5 mg in the once-daily ED dosing section, while current generic tadalafil labels commonly list an actual 2.5 mg tablet presentation.
This is why current tablet availability should be tied to the exact product and manufacturer rather than reconstructed from a dosing instruction. The apparent mismatch is a product-listing issue, not evidence that 2.5 mg has disappeared from tadalafil dosing terminology.
| Current Label Context | What Is Listed |
|---|---|
| Branded Cialis — Dosage Forms and Strengths | 5 mg, 10 mg, 20 mg tablets |
| Branded Cialis — once-daily ED dosing | Dosing instructions still reference 2.5 mg |
| Current generic Cialis-reference tadalafil labels | Commonly list 2.5 mg, 5 mg, 10 mg and 20 mg tablets |
| Practical implication | Check the current label for the specific supplied product |
Tadalafil tablets can be used within once-daily or as-needed ED frameworks depending on the applicable product label. Those terms describe scheduling and dose architecture rather than different active ingredients or fundamentally different kinds of tablets.
This tablet page therefore keeps regimen detail intentionally brief. The full daily framework is covered on Daily Tadalafil, the event-linked framework on As-Needed Tadalafil, and their direct comparison on Daily vs As-Needed Tadalafil.
| Term | What It Describes |
|---|---|
| Once daily | A regular scheduling framework |
| As needed | An ED framework linked to anticipated sexual activity |
| Tadalafil tablet | The physical dosage form used in either framework |
| Different active molecules? | No; the active ingredient remains tadalafil |
Cialis is a proprietary tadalafil tablet product rather than another name for every tadalafil tablet. Current U.S. labeling identifies it as a film-coated oral tablet product in ED, BPH and combined ED/BPH contexts.
Its brand identity, labeled presentation and physical characteristics belong to Cialis specifically. The full product profile is covered on Cialis, while the drug-brand relationship is explained on Tadalafil and Cialis.
| Cialis Attribute | Product Context |
|---|---|
| Active ingredient | Tadalafil |
| Dosage form | Film-coated oral tablet |
| Brand identity | Cialis |
| Current U.S. indication categories | ED, BPH and ED/BPH |
| Does 'tadalafil tablet' always mean Cialis? | No |
FDA-approved generic tadalafil tablets must meet the applicable requirements for the referenced product, including the relevant active ingredient, strength, dosage form, route, quality and bioequivalence standards. Approval does not require each manufacturer's tablet to have the same color, shape or inactive ingredients as the brand.
These permitted finished-product differences explain why two approved tadalafil tablets may look different even when they represent the same strength and regulatory drug context. The deeper generic identity question belongs on Generic Tadalafil, while systemic equivalence is covered on Tadalafil Bioequivalence.
| Tablet Characteristic | Generic Relationship |
|---|---|
| Active ingredient | Must correspond to the referenced tadalafil product |
| Strength | Must match the referenced strength for that generic approval |
| Dosage form | Tablet when referencing the corresponding tablet product |
| Route | Oral |
| Bioequivalence | Must satisfy applicable FDA requirements |
| Color / shape / appearance | Can differ |
| Inactive ingredients | Can differ within applicable regulatory requirements |
There is no single universal appearance for a tadalafil tablet. Branded Cialis uses its own shape and markings, Adcirca has a separate tablet appearance, and generic manufacturers can use other approved colors, shapes and imprint codes.
A tablet should therefore not be identified solely because it resembles a familiar Cialis image. Product packaging, pharmacy labeling and the actual imprint provide more reliable identification context.
| Physical Feature | Can It Vary? |
|---|---|
| Color | Yes |
| Shape | Yes |
| Tablet size | Yes |
| Imprint | Yes |
| Coating | Product-specific |
| Active drug in a tadalafil tablet | Tadalafil |
A finished tablet contains more than tadalafil. Excipients may be used as fillers, binders, disintegrants, coloring agents or coating components, and the exact formulation can differ among branded and generic products.
Those differences do not mean the active molecule has changed, but they can matter when someone needs to check a specific ingredient. The ingredient list for the actual supplied product is therefore more useful than a generic list of 'tadalafil tablet ingredients.'
| Tablet Component | Relationship Across Products |
|---|---|
| Tadalafil | Active pharmaceutical ingredient |
| Fillers / binders | Can vary |
| Coloring agents | Can vary |
| Coating ingredients | Can vary |
| Exact excipient list | Product-specific |
Current Adcirca labeling identifies orange, film-coated, almond-shaped 20 mg tadalafil tablets in the PAH, WHO Group 1 context. This provides a clear example of the same active molecule and a familiar tablet strength appearing outside the Cialis ED/BPH framework.
A 20 mg tadalafil tablet therefore cannot be classified as an ED product simply from its milligram value. Product identity and labeling remain essential, and the relationship is covered further on Tadalafil and Adcirca.
| Adcirca Tablet Feature | Current Product Context |
|---|---|
| Active ingredient | Tadalafil |
| Strength | 20 mg |
| Appearance | Orange, film-coated, almond-shaped |
| Scoring | Not scored |
| Indication context | PAH, WHO Group 1 |
Tablet scoring and splitting instructions belong to the specific finished product. Current Cialis labeling instructs users not to split Cialis tablets, while current Adcirca labeling describes its 20 mg tablets as not scored.
Generic tadalafil tablets should likewise be handled according to their own labeling. A line, shape or milligram value should not be used to infer that a tablet is suitable for splitting.
| Product Context | Tablet-Handling Point |
|---|---|
| Cialis | Current label instructs not to split the tablet |
| Adcirca | 20 mg tablets are not scored |
| Generic tadalafil | Follow the specific manufacturer's labeling |
Current Cialis and common generic Cialis-reference labels permit tadalafil tablets to be taken without regard to food, while Adcirca labeling permits administration with or without food. This shared feature reflects tadalafil's studied food-effect profile rather than making the different tablet products identical.
Questions about the underlying pharmacokinetic evidence belong on Tadalafil Food Effects.
| Tablet Context | Current Food Language |
|---|---|
| Cialis | May be taken without regard to food |
| Common generic Cialis-reference tadalafil | May be taken without regard to food |
| Adcirca | May be taken with or without food |
Because tablet appearance can vary by manufacturer, identification is strongest when several product details are considered together. The prescription label, original packaging, manufacturer information, strength and tablet imprint provide more useful evidence than color alone.
This becomes especially important when multiple manufacturers sell tadalafil at the same nominal strength. Matching milligrams do not guarantee matching appearance or product identity.
| Identification Clue | What It Helps Establish |
|---|---|
| Prescription label | Drug name, strength and dispensing information |
| Manufacturer packaging | Specific finished-product identity |
| Tablet imprint | Product identification |
| Milligram strength | Amount of tadalafil per tablet |
| Color alone | Insufficient for reliable identification |
Storage requirements apply to the finished tablet product and its packaging rather than to tadalafil as an abstract molecule. Manufacturer labeling provides the relevant storage conditions, container information and expiration details for the supplied tablets.
This page does not duplicate those product-handling rules. The broader topic is covered on Tadalafil Storage and expiration terminology on Tadalafil Expiration.
| Product Detail | Best Source |
|---|---|
| Storage temperature | Specific product label |
| Package configuration | Manufacturer / labeler |
| Expiration | Specific labeled package |
| General storage principles | Tadalafil Storage |
An FDA-approved tadalafil oral suspension also exists through Tadliq in the PAH context. It contains the same active drug but is a different finished dosage form with a liquid formulation and product-specific concentration and administration instructions.
The existence of that suspension does not change the role of this page as the tablet-form guide. Liquid tadalafil belongs on Tadalafil Oral Suspension, while the direct formulation comparison belongs on Tadalafil Tablets vs Oral Suspension.
| Feature | Tablet | Oral Suspension |
|---|---|---|
| Physical form | Solid | Liquid suspension |
| Route | Oral | Oral |
| Active drug | Tadalafil | Tadalafil |
| Example product | Cialis or Adcirca | Tadliq |
Most tablet-related confusion comes from treating brand, strength, indication and regimen as though they were the same product attribute. They are separate layers, so the tablet's actual label matters more than any one visual or numeric clue.
Keeping those attributes separate also prevents a generic tablet from being mistaken for Cialis simply because it contains the same active drug.
| Misunderstanding | More Accurate Interpretation |
|---|---|
| "Every tadalafil tablet is Cialis" | No; Cialis, Adcirca and generic products can all contain tadalafil in tablet form |
| "All tadalafil tablet products supply exactly the same strengths" | No; current strength presentation depends on the specific product |
| "A 20 mg tadalafil tablet must be for ED" | No; 20 mg also exists in the PAH tablet context |
| "Generic tadalafil must look like Cialis" | No; approved generics can differ in appearance |
| "Strength tells me which regimen to use" | No; regimen belongs to the applicable label and prescribing context |
| "Daily and as-needed tadalafil are different active drugs" | No; the distinction is in scheduling and dose framework |
| "Any tadalafil tablet can be split" | No; scoring and splitting instructions are product-specific |
Tadalafil tablets are solid oral dosage forms containing tadalafil as the active ingredient. They are supplied through several branded and generic product contexts rather than one universal tadalafil tablet product.
Current generic tadalafil labels in the Cialis-reference context commonly list 2.5 mg, 5 mg, 10 mg and 20 mg tablets. Individual branded and PAH product listings can differ, so strength should be checked against the specific current label.
The current U.S. branded Cialis label lists 5 mg, 10 mg and 20 mg in its Dosage Forms and Strengths section, while its once-daily ED dosing instructions still reference 2.5 mg. Current generic tadalafil products can still list a 2.5 mg tablet presentation.
No. Strength is the amount of tadalafil contained in one tablet, while dose and regimen describe how much is used and how treatment is scheduled within a specific clinical context.
Yes. A milligram value is not a unique indication identifier. For example, 20 mg tadalafil exists in both ED-related tablet products and the separate PAH tablet product landscape.
No. Twenty-milligram tadalafil tablets can be supplied as branded or generic ED-related products and also appear in the Adcirca PAH context.
No. Cialis is one branded tadalafil tablet product. Adcirca and numerous generic products also contain tadalafil in tablet form.
Current U.S. Adcirca labeling identifies 20 mg tadalafil tablets in the pulmonary arterial hypertension product context.
No. FDA-approved generic tablets can differ in color, shape and certain inactive ingredients while meeting the applicable requirements for the referenced drug product.
Different manufacturers can use different approved shapes, colors, imprint systems, coatings and inactive ingredients. Those are finished-product characteristics rather than changes to tadalafil itself.
Yes. Exact excipients can differ among branded and generic tadalafil tablets, so the label for the specific supplied product should be checked when an ingredient matters.
Splitting instructions are product-specific. Current Cialis labeling says not to split Cialis tablets, while current Adcirca tablets are described as not scored; generic products should be handled according to their own labeling.
Current Cialis and common generic Cialis-reference labels permit administration without regard to food, while Adcirca labeling permits administration with or without food.
They use the same active drug and tablet dosage form. Daily and as-needed describe different treatment schedules rather than different tadalafil molecules.
Use the prescription label, original packaging, manufacturer information and tablet imprint rather than relying only on color, shape or strength.
No. An FDA-approved tadalafil oral suspension also exists through Tadliq in the PAH product context.